NewYork-Presbyterian working on machine learning analytics to combat opioid crisis
February 06, 2019 / Bill Siwicki
NewYork-Presbyterian, a prominent academic health system, is working with machine learning vendor Splunk to develop new data analytics tools that prevent the potential diversion of controlled substances such as opioids. NewYork-Presbyterian approached Splunk to develop the controlled substance monitoring platform, while also enhancing patient privacy, because of the vendor’s products’ ability to synthesize Big Data analytics with a massive volume and a variety of data from hundreds of clinical applications, systems and data sources, the health system said. NewYork-Presbyterian, which currently uses Splunk Enterprise and Splunk Enterprise Security to monitor IT security operations, concluded that the same principles could be used to build a platform to more closely safeguard controlled substances and other medications, including opioids, and ultimately benefit the greater healthcare community as a public good, the health system said.